It an excellent session thank u so much for sharing this information.
@MegaAS1979Ай бұрын
How if the parameter is not showing in the Final Parameter Pivot - though you have it in the partial area setting
@S457512 ай бұрын
A Machine Learning Approach for Solving Delay Differential Equations Arising from the Modeling of Cell Division and Growth mam mujay yay topic explain kir Dy plz
@TRADITIONLAMINIATURE3 ай бұрын
Hello I hope you are well. I visited your KZbin Channel. Your content is Excellent. But your Channel is not growing, Because your Content title and Description are not SEO-friendly and do not have Enough Rank tags. This is why there is no Content Coming to the top of KZbin. As a result, your video SEO Score is very low, according to VidiQ, (your channel's video's SEO score is 12.1/ out of 100, which should be 80+). If you want, I can make it 80+, which will help your channel grow faster. If you SEO your videos Properly then the Channel Progress will be very Fast & Subscribers and Views will Increase. If you want I can solve problems and help you rank your videos Better. If you are Interested Please Let me know. Best Regards, AL-AMIN (KZbin Video SEO Expert)
@jrzy493 ай бұрын
Science!!!
@Jimo2255 ай бұрын
what is the cost of a treatment?
@jrzy493 ай бұрын
why? just ask to get it from your doctor
@littlemushroom-z9w6 ай бұрын
Can ADDL be used in model fit?
@borisyoutu200911 ай бұрын
Where I can download these demo datasets? Thanks!
@OliviaCauvi Жыл бұрын
Can you say a little bit about how this applies to class I devices, where clinical data may be limited and evaluations based mostly on preclinical data?
@mikedodger7898 Жыл бұрын
37:59 This is a very good way to validate AI, and is the approach I've been using.
@mikedodger7898 Жыл бұрын
32:16 "... create an accurate prompt" is a good point, but my lay person tests have not shown that hallucinations can be avoided.
@mikedodger7898 Жыл бұрын
30:07 - This is a good conversation about how to put AI insights into. Something like "Treat it like a colleagues that has ideas then ask for a justification"
@hoshengyang Жыл бұрын
Good job, Ping!
@irisschmitt9052 Жыл бұрын
Unfortunately hard to understand
@varshareddy-we3dv Жыл бұрын
Hi madam,thank you alot,it's very useful information for regulatory personnel.please do upload some other ectd related and things.
@Lance1572 Жыл бұрын
Great❤
@israaal-ani770 Жыл бұрын
Many thanks for the vedio
@harrytsien3211 Жыл бұрын
Enjoyable talk! Thanks for sharing!
@Jaeoh.woof765 Жыл бұрын
nice talk. thanks.
@RAVISOMABATTINI Жыл бұрын
INFORMATIVE
@jahnavichandina7511 Жыл бұрын
Hi .I would like to know what format we need to upload documents..
@naturalanimalpedia Жыл бұрын
Great contents!
@reginar0529 Жыл бұрын
Very useful. Love the Resident Writer initiative!
@DDT-f8s Жыл бұрын
Thank you Certara for such an insightful presentation... I hope one-day to be part of your wonderful team of experts.
@arvindraghavan8993 Жыл бұрын
Excellent content, balanced and well-thought-out responses to questions (which were also top-notch!). The video however was blurred throughout the session (so not an issue with my internet signal quality). Cold this please be rectified?
@BUY_YOUTUBE_VIEWS_676 Жыл бұрын
Your videos are the first thing I watch
@mrchapss Жыл бұрын
please see the updated demo here for version 2, (released Oct 2022); kzbin.info/www/bejne/f3KQeZWAprR8qJo
@JuliyanJoshi2 жыл бұрын
How to use downloaded template
@jishnuprasad93122 жыл бұрын
any crack version is available ?
@albarone872 жыл бұрын
فخورة فيك دكتور جعل العلماء والدكاترة السعوديين ❤
@keyu52142 жыл бұрын
where to input the bioavailability data to the model for simulation?
@tallasrinadh2 жыл бұрын
Can get excel sheet data it will be useful for me... For practice purpose..
@berndwendt79432 жыл бұрын
Please send an email to [email protected] and we can address your request
@letongsong2 жыл бұрын
Nice job!
@Certara2 жыл бұрын
Thank you!
@mrchapss2 жыл бұрын
updated templates and instruction are available here; www.certarauniversity.com/store/2383230-106-fl-free-phoenix-templates-for-bioequivalence-regulatory-guidances
@mrchapss2 жыл бұрын
Working with R via Integral client starts at 30 mins, kzbin.info/www/bejne/i4OQZnWLlJaCfpo
@rnavsdna9772 жыл бұрын
How can we critically appraise Single arm trial ? Which toolkit ? Please suggest
@mgbhangale2 жыл бұрын
Thanks for sharing viodeo...I am facing issue after close its seems run in background, each time I have to logout windows 10 to again start the application... Could you help with solution
@rebeccaturner71862 жыл бұрын
you need to adjust the content
@grantfisher51862 жыл бұрын
uh
@aditibahadur80812 жыл бұрын
Can we put in a csv file directly for pirahana?
@mrchapss2 жыл бұрын
Hi Aditi, I don't quite understand your question, CSVs are of course an acceptable data format. What is in the CSV, source concentrations, run results? Please can you either go to our user forum; support.certara.com/forums/forum/37-pirana-and-rsnlme/ or contact Certara support directly with more details of your question/problem. Thanks, Simon
@prajwalakarnati42632 жыл бұрын
Wow!! That's amazing
@poojagupta-my6ss3 жыл бұрын
Why did you selected cancer population instead of healthy population while checking the effect of diltizam
@jonjones13363 жыл бұрын
1 Bizarre shortcoming of this study: it did not control for baseline anxiety. We know anxiety is positively correlated with severity of covid illness (though we don't know the direction, if there is causality, this is also bizarre, that how 0 "experts" on earth thought to or bothered to do a study exploring this). We know anxiety and covid both affect breathing. We know that fluvoxamine is an SSRI that is used for ocd which is similar to anxiety. So using basic inferential logic and common sense, when a study has 30% efficacy, which is significant but not that high, one would definitely want to check for this confounding variable: could it be that fluvoxamine is partially or mostly reducing the anxiety, which in turn reduces covid severity? This would have a huge implication: it would mean that fluvoxamine would be good for use in those with anxiety, but may not be that useful for others. My guess for why they did not assess for baseline anxiety is because they either didn't think of this common sense confounding variable, or they deliberately ignored it because they thought it would take too much time to properly assess for baseline anxiety, which would require a structured clinical interview and the use of rating scales. However, even if they gave a brief rating scale to participants, or simply asked 1 question like "do you think you were always more anxious than the average person?", given the large sample size, it would have still resulted in some meaningful findings in this regard. But my guess is the journal would have probably rejected their paper if they did this, because they didn't use the "gold standard" method of structured interviews. This is why "scientism" can be counterproductive. Obviously we should aim to use gold standard methods whenever possible, but in a pandemic for example, when there is no time, it makes no sense to completely ignore important variables or completely reject non-gold standard studies when they can result in quick and practical value. Having said all this, given other studies showing the anti inflammatory properties of fluvoxamine and its action in sigma 1 receptors, I would guess that even aside from anxiety it should likely have some benefit against covid. However, it is frustrating that this study did not control for anxiety to more clearly show/prove such an effect.
@ajaymeena15593 жыл бұрын
Pkd disease gene therepy 🤔
@michaeleckstut74703 жыл бұрын
Well done Gabby!!
@michaeleckstut74703 жыл бұрын
Joshua -- well said, I like the way you emphasized some of the key features and showed the benefits of our Global Submit software!
@tuyenlethile70803 жыл бұрын
CovidImages need to be invested more than half19
@adnanakif78443 жыл бұрын
Demo start around 20 minutes.
@nandadeep9993 жыл бұрын
Interesting.
@Certara3 жыл бұрын
Glad you think so!
@duyle92773 жыл бұрын
The video sound is pretty good, beyond my imagination